_1777294237270_124456903.png&w=48&q=75){kind=small}
Bristol and Nvidia Create New Supercomputer
Bristol Myers Squibb is working to expand its partnership with Nvidia to launch a supercomputer aimed at accelerating drug discovery and development. This supercomputer features the Nvidia DGX SuperPOD platform and is among the most powerful computers dedicated to life sciences, with the goal of reducing costs and overcoming time and financial barriers in the pharmaceutical industry. This collaboration is part of Nvidia's efforts, along with other pharmaceutical companies like Eli Lilly and Amgen, to enhance artificial intelligence capabilities in the healthcare sector.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)